Cocaine-like price hike: China’s new cancer drug is approved in the US but will cost 30 times more

Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.

Following the FDA’s approval of Toripalimab, two more Chinese-made cancer drugs have received approval for distribution in the US this month.